Acebutolol
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Acebutolol.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Isosorbide Mononitrate.
Aliskiren
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Aliskiren.
Advertisement
Amifostine
The risk or severity of adverse effects can be increased when Amifostine is combined with Isosorbide Mononitrate.
Amifostine Anhydrous
The risk or severity of adverse effects can be increased when Amifostine is combined with Isosorbide Mononitrate.
Amiloride
The risk or severity of adverse effects can be increased when Amiloride is combined with Isosorbide Mononitrate.
Advertisement
Amiodarone
The metabolism of Isosorbide Mononitrate can be decreased when combined with Amiodarone.
Amlodipine
The risk or severity of adverse effects can be increased when Amlodipine is combined with Isosorbide Mononitrate.
Amobarbital
Amobarbital may increase the hypotensive activities of Isosorbide Mononitrate.
Advertisement
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isosorbide Mononitrate.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Isosorbide Mononitrate.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Amyl Nitrite.
Apalutamide
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Apalutamide.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Isosorbide Mononitrate.
Apraclonidine
The risk or severity of adverse effects can be increased when Apraclonidine is combined with Isosorbide Mononitrate.
Aprepitant
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Aprepitant.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Isosorbide Mononitrate.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Isosorbide Mononitrate.
Atazanavir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Atazanavir.
Atenolol
The risk or severity of adverse effects can be increased when Atenolol is combined with Isosorbide Mononitrate.
Atomoxetine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Atomoxetine.
Avanafil
Avanafil may increase the vasodilatory activities of Isosorbide Mononitrate.
Azilsartan
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Azilsartan medoxomil.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Isosorbide Mononitrate.
Barbital
Barbital may increase the hypotensive activities of Isosorbide Mononitrate.
Benazepril
The risk or severity of adverse effects can be increased when Benazepril is combined with Isosorbide Mononitrate.
Bendroflumethiazide
The risk or severity of adverse effects can be increased when Bendroflumethiazide is combined with Isosorbide Mononitrate.
Bepridil
The risk or severity of adverse effects can be increased when Bepridil is combined with Isosorbide Mononitrate.
Betaxolol
The risk or severity of adverse effects can be increased when Betaxolol is combined with Isosorbide Mononitrate.
Bisoprolol
The risk or severity of adverse effects can be increased when Bisoprolol is combined with Isosorbide Mononitrate.
Boceprevir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Boceprevir.
Bortezomib
The metabolism of Isosorbide Mononitrate can be decreased when combined with Bortezomib.
Bosentan
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Bosentan.
Bretylium
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Bretylium.
Brimonidine
The risk or severity of adverse effects can be increased when Brimonidine is combined with Isosorbide Mononitrate.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Isosorbide Mononitrate.
Bumetanide
The risk or severity of adverse effects can be increased when Bumetanide is combined with Isosorbide Mononitrate.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Isosorbide Mononitrate.
Canagliflozin
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Canagliflozin.
Canagliflozin Anhydrous
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Canagliflozin.
Candesartan Cilexetil
The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Isosorbide Mononitrate.
Captopril
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Captopril.
Carbamazepine
The metabolism of Isosorbide Mononitrate can be increased when combined with Carbamazepine.
Carteolol
The risk or severity of adverse effects can be increased when Carteolol is combined with Isosorbide Mononitrate.
Carvedilol
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Carvedilol.
Ceritinib
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Ceritinib.
Chlorothiazide
The risk or severity of adverse effects can be increased when Chlorothiazide is combined with Isosorbide Mononitrate.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Isosorbide Mononitrate.
Chlorthalidone
The risk or severity of adverse effects can be increased when Chlorthalidone is combined with Isosorbide Mononitrate.
Cilazapril
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Cilazapril.
Clarithromycin
The metabolism of Isosorbide Mononitrate can be decreased when combined with Clarithromycin.
Clemastine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Clemastine.
Clevidipine
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Isosorbide Mononitrate.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Isosorbide Mononitrate.
Clonidine
The risk or severity of adverse effects can be increased when Clonidine is combined with Isosorbide Mononitrate.
Clotrimazole
The metabolism of Isosorbide Mononitrate can be decreased when combined with Clotrimazole.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Isosorbide Mononitrate.
Cobicistat
The metabolism of Isosorbide Mononitrate can be decreased when combined with Cobicistat.
Conivaptan
The serum concentration of Conivaptan can be increased when it is combined with Isosorbide Mononitrate.
Crizotinib
The metabolism of Isosorbide Mononitrate can be decreased when combined with Crizotinib.
Cyclosporine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Cyclosporine.
Dabrafenib
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Dabrafenib.
Dapagliflozin
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Dapagliflozin.
Dapsone
The risk or severity of adverse effects can be increased when Dapsone is combined with Isosorbide Mononitrate.
Darunavir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Darunavir.
Dasatinib
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Dasatinib.
Dasatinib Anhydrous
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Dasatinib.
Deferasirox
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Deferasirox.
Delavirdine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Delavirdine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Isosorbide Mononitrate.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Isosorbide Mononitrate.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Diclofenamide.
Dihydroergotamine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Dihydroergotamine.
Diltiazem
The metabolism of Isosorbide Mononitrate can be decreased when combined with Diltiazem.
Dinutuximab
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Dipyridamole is combined with Isosorbide Mononitrate.
Doxazosin
The risk or severity of adverse effects can be increased when Doxazosin is combined with Isosorbide Mononitrate.
Doxycycline
The metabolism of Isosorbide Mononitrate can be decreased when combined with Doxycycline.
Doxycycline Anhydrous
The metabolism of Isosorbide Mononitrate can be decreased when combined with Doxycycline.
Dronedarone
The metabolism of Isosorbide Mononitrate can be decreased when combined with Dronedarone.
Duloxetine
Isosorbide Mononitrate may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Empagliflozin.
Enalapril
The risk or severity of adverse effects can be increased when Enalapril is combined with Isosorbide Mononitrate.
Enalaprilat
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Isosorbide Mononitrate.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Enalaprilat is combined with Isosorbide Mononitrate.
Enzalutamide
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Enzalutamide.
Eplerenone
The risk or severity of adverse effects can be increased when Eplerenone is combined with Isosorbide Mononitrate.
Epoprostenol
The risk or severity of adverse effects can be increased when Epoprostenol is combined with Isosorbide Mononitrate.
Eprosartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Isosorbide Mononitrate.
Erythromycin
The metabolism of Isosorbide Mononitrate can be decreased when combined with Erythromycin.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Isosorbide Mononitrate.
Ethacrynate
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Isosorbide Mononitrate.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Etacrynic acid is combined with Isosorbide Mononitrate.
Ethanol
Ethanol may increase the vasodilatory activities of Isosorbide Mononitrate.
Felodipine
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Felodipine.
Fenoldopam
The risk or severity of adverse effects can be increased when Fenoldopam is combined with Isosorbide Mononitrate.
Fluconazole
The metabolism of Isosorbide Mononitrate can be decreased when combined with Fluconazole.
Fluvoxamine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Fluvoxamine.
Fosamprenavir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Fosamprenavir.
Fosaprepitant
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Fosaprepitant.
Fosinopril
The risk or severity of adverse effects can be increased when Fosinopril is combined with Isosorbide Mononitrate.
Fosphenytoin
The metabolism of Isosorbide Mononitrate can be increased when combined with Fosphenytoin.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Isosorbide Mononitrate.
Fusidate
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Fusidic Acid.
Fusidic Acid
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Fusidic Acid.
Guanfacine
The risk or severity of adverse effects can be increased when Guanfacine is combined with Isosorbide Mononitrate.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Isosorbide Mononitrate.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Isosorbide Mononitrate.
Hydralazine
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Hydralazine.
Hydrochlorothiazide
The risk or severity of adverse effects can be increased when Hydrochlorothiazide is combined with Isosorbide Mononitrate.
Hydroflumethiazide
The risk or severity of adverse effects can be increased when Hydroflumethiazide is combined with Isosorbide Mononitrate.
Hypoxis hemerocallidea root extract
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with St. John's Wort.
Idelalisib
The metabolism of Isosorbide Mononitrate can be decreased when combined with Idelalisib.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Isosorbide Mononitrate.
Imatinib
The metabolism of Isosorbide Mononitrate can be decreased when combined with Imatinib.
Imidapril
The risk or severity of adverse effects can be increased when Imidapril is combined with Isosorbide Mononitrate.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Isosorbide Mononitrate.
Indapamide
The risk or severity of adverse effects can be increased when Indapamide is combined with Isosorbide Mononitrate.
Indinavir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Indinavir.
INDINAVIR ANHYDROUS
The metabolism of Isosorbide Mononitrate can be decreased when combined with Indinavir.
Indoramin
The risk or severity of adverse effects can be increased when Indoramin is combined with Isosorbide Mononitrate.
Irbesartan
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Irbesartan.
Isavuconazole
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Isavuconazole.
Isavuconazonium
The metabolism of Isosorbide Mononitrate can be decreased when combined with Isavuconazonium.
Isocarboxazid
The risk or severity of adverse effects can be increased when Isocarboxazid is combined with Isosorbide Mononitrate.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Isosorbide Mononitrate.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Isosorbide Dinitrate is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Isoxsuprine.
Isradipine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Isradipine.
Itraconazole
The metabolism of Isosorbide Mononitrate can be decreased when combined with Itraconazole.
Ivacaftor
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Ivacaftor.
Ketoconazole
The metabolism of Isosorbide Mononitrate can be decreased when combined with Ketoconazole.
Labetalol
The risk or severity of adverse effects can be increased when Labetalol is combined with Isosorbide Mononitrate.
Lacidipine
Isosorbide Mononitrate may increase the hypotensive activities of Lacidipine.
Lercanidipine
The risk or severity of adverse effects can be increased when Lercanidipine is combined with Isosorbide Mononitrate.
Levobunolol
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Isosorbide Mononitrate.
Levodopa
Isosorbide Mononitrate may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Isosorbide Mononitrate.
Lisinopril
The risk or severity of adverse effects can be increased when Lisinopril is combined with Isosorbide Mononitrate.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Lisinopril is combined with Isosorbide Mononitrate.
Lofexidine
The risk or severity of adverse effects can be increased when Lofexidine is combined with Isosorbide Mononitrate.
Lopinavir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Lopinavir.
Losartan
The risk or severity of adverse effects can be increased when Losartan is combined with Isosorbide Mononitrate.
Lovastatin
The metabolism of Isosorbide Mononitrate can be decreased when combined with Lovastatin.
Luliconazole
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Luliconazole.
Lumacaftor
The metabolism of Isosorbide Mononitrate can be increased when combined with Lumacaftor.
Mannitol
The risk or severity of adverse effects can be increased when Mannitol is combined with Isosorbide Mononitrate.
Mecamylamine
The risk or severity of adverse effects can be increased when Mecamylamine is combined with Isosorbide Mononitrate.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Isosorbide Mononitrate.
Mepirodipine
The risk or severity of adverse effects can be increased when Barnidipine is combined with Isosorbide Mononitrate.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Isosorbide Mononitrate.
Methohexital
Methohexital may increase the hypotensive activities of Isosorbide Mononitrate.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Isosorbide Mononitrate.
Methyldopa
The risk or severity of adverse effects can be increased when Methyldopa is combined with Isosorbide Mononitrate.
METHYLDOPA ANHYDROUS
The risk or severity of adverse effects can be increased when Methyldopa is combined with Isosorbide Mononitrate.
Metipranolol
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Metipranolol.
Metolazone
The risk or severity of adverse effects can be increased when Metolazone is combined with Isosorbide Mononitrate.
Metoprolol
The risk or severity of adverse effects can be increased when Metoprolol is combined with Isosorbide Mononitrate.
Mifepristone
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Mifepristone.
Minoxidil
The risk or severity of adverse effects can be increased when Minoxidil is combined with Isosorbide Mononitrate.
Mitotane
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Mitotane.
Moexipril
The risk or severity of adverse effects can be increased when Moexipril is combined with Isosorbide Mononitrate.
Molsidomine
Molsidomine may increase the hypotensive activities of Isosorbide Mononitrate.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Isosorbide Mononitrate.
Moxonidine
The risk or severity of adverse effects can be increased when Moxonidine is combined with Isosorbide Mononitrate.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Isosorbide Mononitrate.
Nadolol
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Nadolol.
Nebivolol
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Nebivolol.
Nefazodone
The metabolism of Isosorbide Mononitrate can be decreased when combined with Nefazodone.
Nelfinavir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Nelfinavir.
Nesiritide
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Nesiritide.
Netupitant
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Netupitant.
Nevirapine
The metabolism of Isosorbide Mononitrate can be increased when combined with Nevirapine.
Nicardipine
The risk or severity of adverse effects can be increased when Nicardipine is combined with Isosorbide Mononitrate.
Nicorandil
Nicorandil may increase the hypotensive activities of Isosorbide Mononitrate.
Nifedipine
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Nifedipine.
Nilotinib
The metabolism of Isosorbide Mononitrate can be decreased when combined with Nilotinib.
Nilvadipine
The risk or severity of adverse effects can be increased when Nilvadipine is combined with Isosorbide Mononitrate.
Nimodipine
The risk or severity of adverse effects can be increased when Nimodipine is combined with Isosorbide Mononitrate.
Nisoldipine
The risk or severity of adverse effects can be increased when Nisoldipine is combined with Isosorbide Mononitrate.
Nitrendipine
The risk or severity of adverse effects can be increased when Nitrendipine is combined with Isosorbide Mononitrate.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Isosorbide Mononitrate.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Isosorbide Mononitrate.
Nitroprusside
The risk or severity of adverse effects can be increased when Nitroprusside is combined with Isosorbide Mononitrate.
Obinutuzumab
The risk or severity of adverse effects can be increased when Obinutuzumab is combined with Isosorbide Mononitrate.
Olaparib
The metabolism of Isosorbide Mononitrate can be decreased when combined with Olaparib.
Olmesartan
The risk or severity of adverse effects can be increased when Olmesartan is combined with Isosorbide Mononitrate.
Osimertinib
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Osimertinib.
Oxprenolol
The risk or severity of adverse effects can be increased when Oxprenolol is combined with Isosorbide Mononitrate.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Isosorbide Mononitrate.
Palbociclib
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Palbociclib.
Papaverine
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Papaverine.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Isosorbide Mononitrate.
Penbutolol
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Penbutolol.
Pentobarbital
The metabolism of Isosorbide Mononitrate can be increased when combined with Pentobarbital.
Perindopril
The risk or severity of adverse effects can be increased when Perindopril is combined with Isosorbide Mononitrate.
Phenelzine
The risk or severity of adverse effects can be increased when Phenelzine is combined with Isosorbide Mononitrate.
Phenobarbital
The metabolism of Isosorbide Mononitrate can be increased when combined with Phenobarbital.
Phenoxybenzamine
The risk or severity of adverse effects can be increased when Phenoxybenzamine is combined with Isosorbide Mononitrate.
Phentolamine
The risk or severity of adverse effects can be increased when Phentolamine is combined with Isosorbide Mononitrate.
Phentolamine Mesylate
The risk or severity of adverse effects can be increased when Phentolamine is combined with Isosorbide Mononitrate.
Phenytoin
The metabolism of Isosorbide Mononitrate can be increased when combined with Phenytoin.
Pindolol
The risk or severity of adverse effects can be increased when Pindolol is combined with Isosorbide Mononitrate.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Isosorbide Mononitrate.
Posaconazole
The metabolism of Isosorbide Mononitrate can be decreased when combined with Posaconazole.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Isosorbide Mononitrate.
Prazosin
The risk or severity of adverse effects can be increased when Prazosin is combined with Isosorbide Mononitrate.
Prilocaine
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Prilocaine.
Primidone
The metabolism of Isosorbide Mononitrate can be increased when combined with Primidone.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Isosorbide Mononitrate.
Propranolol
The risk or severity of adverse effects can be increased when Propranolol is combined with Isosorbide Mononitrate.
Quetiapine
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Quetiapine.
Quinapril
The risk or severity of adverse effects can be increased when Quinapril is combined with Isosorbide Mononitrate.
Ramipril
The risk or severity of adverse effects can be increased when Ramipril is combined with Isosorbide Mononitrate.
Ranolazine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Ranolazine.
Rasagiline
The risk or severity of adverse effects can be increased when Rasagiline is combined with Isosorbide Mononitrate.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Isosorbide Mononitrate.
Reserpine
The risk or severity of adverse effects can be increased when Reserpine is combined with Isosorbide Mononitrate.
Rifabutin
The metabolism of Isosorbide Mononitrate can be increased when combined with Rifabutin.
Rifampin
The metabolism of Isosorbide Mononitrate can be increased when combined with Rifampicin.
Rifapentine
The metabolism of Isosorbide Mononitrate can be increased when combined with Rifapentine.
Riociguat
Isosorbide Mononitrate may increase the hypotensive activities of Riociguat.
Risperidone
Isosorbide Mononitrate may increase the hypotensive activities of Risperidone.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Isosorbide Mononitrate.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Isosorbide Mononitrate.
Rosiglitazone
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Rosiglitazone.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Isosorbide Mononitrate.
Rucaparib
The metabolism of Isosorbide Mononitrate can be decreased when combined with Rucaparib.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Isosorbide Mononitrate.
Saquinavir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Saquinavir.
Saquinavir Mesylate
The metabolism of Isosorbide Mononitrate can be decreased when combined with Saquinavir.
Sarilumab
The therapeutic efficacy of Isosorbide Mononitrate can be decreased when used in combination with Sarilumab.
Secobarbital
Secobarbital may increase the hypotensive activities of Isosorbide Mononitrate.
Selegiline
The risk or severity of adverse effects can be increased when Selegiline is combined with Isosorbide Mononitrate.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Isosorbide Mononitrate.
Sildenafil
Sildenafil may increase the vasodilatory activities of Isosorbide Mononitrate.
Siltuximab
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Siltuximab.
Simeprevir
The serum concentration of Isosorbide Mononitrate can be increased when it is combined with Simeprevir.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Isosorbide Mononitrate.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Isosorbide Mononitrate.
ST. JOHN'S WORT EXTRACT
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with St. John's Wort.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Isosorbide Mononitrate.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Isosorbide Mononitrate.
Sulfisoxazole
The metabolism of Isosorbide Mononitrate can be decreased when combined with Sulfisoxazole.
Tadalafil
Tadalafil may increase the vasodilatory activities of Isosorbide Mononitrate.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Isosorbide Mononitrate.
Telaprevir
The metabolism of Isosorbide Mononitrate can be decreased when combined with Telaprevir.
Telithromycin
The metabolism of Isosorbide Mononitrate can be decreased when combined with Telithromycin.
Telmisartan
The risk or severity of adverse effects can be increased when Telmisartan is combined with Isosorbide Mononitrate.
Terazosin
The risk or severity of adverse effects can be increased when Isosorbide Mononitrate is combined with Terazosin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Isosorbide Mononitrate.
Thiamylal
Thiamylal may increase the hypotensive activities of Isosorbide Mononitrate.
Thiopental
Thiopental may increase the hypotensive activities of Isosorbide Mononitrate.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Isosorbide Mononitrate.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Isosorbide Mononitrate.
Ticlopidine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Ticlopidine.
Timolol
The risk or severity of adverse effects can be increased when Timolol is combined with Isosorbide Mononitrate.
Timolol Anhydrous
The risk or severity of adverse effects can be increased when Timolol is combined with Isosorbide Mononitrate.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Isosorbide Mononitrate.
Tocilizumab
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Tocilizumab.
Tolazoline
The risk or severity of adverse effects can be increased when Tolazoline is combined with Isosorbide Mononitrate.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Isosorbide Mononitrate.
Torsemide
The risk or severity of adverse effects can be increased when Torasemide is combined with Isosorbide Mononitrate.
Trandolapril
The risk or severity of adverse effects can be increased when Trandolapril is combined with Isosorbide Mononitrate.
Tranylcypromine
The risk or severity of adverse effects can be increased when Tranylcypromine is combined with Isosorbide Mononitrate.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Isosorbide Mononitrate.
Triamterene
The risk or severity of adverse effects can be increased when Triamterene is combined with Isosorbide Mononitrate.
Valsartan
The risk or severity of adverse effects can be increased when Valsartan is combined with Isosorbide Mononitrate.
Vardenafil
Vardenafil may increase the vasodilatory activities of Isosorbide Mononitrate.
Vemurafenib
The serum concentration of Isosorbide Mononitrate can be decreased when it is combined with Vemurafenib.
Venlafaxine
The metabolism of Isosorbide Mononitrate can be decreased when combined with Venlafaxine.
Verapamil
The metabolism of Isosorbide Mononitrate can be decreased when combined with Verapamil.
Voriconazole
The metabolism of Isosorbide Mononitrate can be decreased when combined with Voriconazole.
Ziprasidone
The metabolism of Isosorbide Mononitrate can be decreased when combined with Ziprasidone.
